UA105278C2 - Способ получения каталитически активных антител (абзимов) с сиалидазной активностью - Google Patents
Способ получения каталитически активных антител (абзимов) с сиалидазной активностьюInfo
- Publication number
- UA105278C2 UA105278C2 UAA201210528A UAA201210528A UA105278C2 UA 105278 C2 UA105278 C2 UA 105278C2 UA A201210528 A UAA201210528 A UA A201210528A UA A201210528 A UAA201210528 A UA A201210528A UA 105278 C2 UA105278 C2 UA 105278C2
- Authority
- UA
- Ukraine
- Prior art keywords
- catalytically
- active antibodies
- production
- sialidase activity
- abzymes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201210528A UA105278C2 (ru) | 2012-09-06 | 2012-09-06 | Способ получения каталитически активных антител (абзимов) с сиалидазной активностью |
PCT/IB2013/001908 WO2014037785A2 (fr) | 2012-09-06 | 2013-09-05 | Anticorps catalytiques et leurs utilisations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201210528A UA105278C2 (ru) | 2012-09-06 | 2012-09-06 | Способ получения каталитически активных антител (абзимов) с сиалидазной активностью |
Publications (1)
Publication Number | Publication Date |
---|---|
UA105278C2 true UA105278C2 (ru) | 2014-04-25 |
Family
ID=49885295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201210528A UA105278C2 (ru) | 2012-09-06 | 2012-09-06 | Способ получения каталитически активных антител (абзимов) с сиалидазной активностью |
Country Status (2)
Country | Link |
---|---|
UA (1) | UA105278C2 (fr) |
WO (1) | WO2014037785A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102581747B1 (ko) * | 2016-07-01 | 2023-09-22 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 표적 세포 표면 편집을 위한 접합체 |
AU2019205912A1 (en) | 2018-01-03 | 2020-07-16 | Palleon Pharmaceuticals Inc. | Recombinant human sialidases, sialidase fusion proteins, and methods of using the same |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
JPS5896026A (ja) | 1981-10-30 | 1983-06-07 | Nippon Chemiphar Co Ltd | 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤 |
CH652145A5 (de) | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
DE3380726D1 (en) | 1982-06-24 | 1989-11-23 | Japan Chem Res | Long-acting composition |
US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
CA1294215C (fr) | 1986-10-27 | 1992-01-14 | Ze'ev Shaked | Compositions pharmaceutiques d'interferon beta recombinant et methodes de formulation |
CA1292686C (fr) | 1986-10-27 | 1991-12-03 | Ze'ev Shaked | Compositions pharmaceutiques d'interleukine-2 recombinante et procede de fabrication |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
WO1991010448A1 (fr) | 1990-01-19 | 1991-07-25 | German Cancer Research Center | Antigene de surface cellulaire associe a l'apoptose cellulaire |
US5463028A (en) | 1992-04-03 | 1995-10-31 | The Trustees Of Columbia University In The City Of New York | Reagents for generating a polyclonal hydrolytic antibody response against cocaine and the monoclonal hydrolytic antibodies against cocaine derived through these reagents |
US5770208A (en) | 1996-09-11 | 1998-06-23 | Nabi | Staphylococcus aureus B-linked hexosamine antigen |
US6268488B1 (en) * | 1999-05-25 | 2001-07-31 | Barbas, Iii Carlos F. | Prodrug activation using catalytic antibodies |
FR2825154B1 (fr) * | 2001-05-22 | 2004-01-30 | Univ Compiegne Tech | Composes capables de moduler l'activite et de stimuler la production d'un anticorps catalytique |
ES2486269T3 (es) * | 2001-10-22 | 2014-08-18 | The Scripps Research Institute | Compuestos que eligen anticuerpos como diana |
US20030087435A1 (en) | 2001-11-06 | 2003-05-08 | Brandt Jeffrey J. | Catalytic antibodies raised against sarin; an organophosphorous anticholinesterase, and an antigen and process for the preparation thereof |
DE60331310D1 (de) | 2002-06-26 | 2010-04-01 | Univ Louisville Res Found | Verfahren zum apoptosenachweis |
US20060074047A1 (en) * | 2004-10-06 | 2006-04-06 | Cross Alan S | Method of treating inflammation with inhibitors of sialyl transferases |
CA2624772C (fr) | 2005-10-11 | 2011-11-29 | Centre National De La Recherche Scientifique (Cnrs) | Composes et ensembles pour la detection et le dosage de l'apoptose cellulaire |
WO2007053654A2 (fr) | 2005-10-31 | 2007-05-10 | Cedars-Sinai Medical Center | Procede d'agglutination pour la detection rapide, l'isolement et la quantification de cellules apoptotiques |
-
2012
- 2012-09-06 UA UAA201210528A patent/UA105278C2/ru unknown
-
2013
- 2013-09-05 WO PCT/IB2013/001908 patent/WO2014037785A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014037785A2 (fr) | 2014-03-13 |
WO2014037785A3 (fr) | 2014-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR093377A1 (es) | Anticuerpos anti-notch y conjugados de anticuerpo-farmaco | |
AR088322A1 (es) | Anticuerpos anti-htra1 y metodos de uso | |
AR090017A1 (es) | Agonistas de fgfr1 y sus metodos de uso | |
AR091098A1 (es) | ANTICUERPOS E INMUNOCONJUGADOS CONTRA Ly6E Y METODOS DE USO | |
EP2894242A4 (fr) | Cristal de complexe polymère-métal enveloppant un composé client, son procédé de fabrication, procédé de préparation d'un échantillon pour analyse de structure cristalline et procédé de détermination de la structure moléculaire d'un composé organique | |
WO2013060867A3 (fr) | Production de protéines hétérodimères | |
CL2015001088A1 (es) | Proceso de elaboración de compuestos derivados de pirimidina (div. sol. 850-13). | |
EA201492057A1 (ru) | Ферментация и способ с псевдодвижущимся слоем | |
EA201490895A1 (ru) | Производство сахарного спирта из биомассы | |
SG11201403204TA (en) | Process for making hmf and hmf derivatives from sugars, with recovery of unreacted sugars suitable for direct fermentation to ethanol | |
AU2012312028A8 (en) | Detection of isotype profiles as signatures for disease | |
MX345069B (es) | Método para la producción de ligandos beta amiloide marcados con 18f. | |
BR112014013862A2 (pt) | processos incluindo de alta produtividade, para fermentar gás de síntese | |
EP2580339A4 (fr) | Système et procédé de production de biocarburants | |
EP3074036A4 (fr) | Préparation d'anticorps à partir de cultures de cellules cho pour la conjugaison | |
DK3342867T3 (da) | Xylanasemutant, fremgangsmåde til fremstilling og anvendelse herfor, og fremgangsmåde til fremstilling af forsukret lignocellulose | |
SG11201505171PA (en) | Method for improving yield of enzymatic preparation of biodiesel from greases | |
IN2014DN09097A (fr) | ||
UA105278C2 (ru) | Способ получения каталитически активных антител (абзимов) с сиалидазной активностью | |
HK1215244A1 (zh) | 用於製備 -溴- -氧雜二環 辛烷- -酮的方法 | |
MY164628A (en) | Catalytic cracking catalyst | |
HK1204011A1 (en) | Method for the production of furan derivatives from glucose d- | |
WO2014008172A3 (fr) | Lignée cellulaire en suspension à haut rendement, son système et son procédé de production | |
MX2012014118A (es) | Metodo para la produccion de ligandos beta amiloide marcados con 18f. | |
MX349985B (es) | Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi. |